ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

May 29, 1998

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

NAB Report To President Makes Pitch for Money, Cites Research Progress

August 9, 1974

UT Southwestern Simmons Cancer Center received $50 million from Simmons family.

November 4, 2005